Regenerative Revival Brings Concierge Stem Cell and Exosome Therapy Directly to Patients' Doors

For most people facing joint pain, the path has looked the same for decades: physical therapy, injections, and eventually a surgery date. Regenerative Revival was built on the premise that there should be another option on the table and that it shouldn't require a clinic waiting room.

Founded by Seth Berge, Founder and CEO, the company has spent more than eight years delivering concierge regenerative medicine, beginning in 2018. What started as a conviction that advanced cellular therapy should be accessible to ordinary people has grown into a nationwide operation: over 100 licensed clinicians, coverage in all 50 states, and more than 6,000 patients treated.

The model is straightforward and unusual. Rather than asking patients to travel to a specialty clinic, Regenerative Revival sends a licensed nurse practitioner to the patient's home to administer stem cell and exosome therapy for joints and soft tissue, under physician oversight. The company's regenerative protocols center on Wharton's Jelly, sourced from ethically donated umbilical cord tissue and one of the richest known sources of high-quality mesenchymal stem cells and growth factors. Every protocol also incorporates stem cell derived exosomes, the signaling vesicles cells use to communicate, which work alongside the cellular component of each treatment.

Clinical rigor sits behind the convenience. Every patient is overseen by Medical Director Dr. Sean Arora, CEO of Arora Health Group, which develops and supervises every protocol and conducts good-faith exams in every state the company serves. Chief Medical Officer Dr. Shannon Arora leads a philosophy of integration rather than fragmentation, the view that regenerative medicine, hormone therapy, and peptide protocols shouldn't live in separate buildings when the same patient needs all three.

That integration is the second half of the business. Alongside in-home regenerative care, Regenerative Revival operates a telehealth arm offering bioidentical hormone therapy, TRT and HRT, clinician-led peptide protocols, NAD+ therapy, and longevity programs, prescribed based on real labs, dispensed through licensed compounding pharmacies, and shipped to the patient's door. One medical team, one patient record, one plan.

Notably, the company also declines patients. "Not every joint is a candidate. If yours isn't, we'll tell you on the consult and send you back to your specialist with a clearer picture," the company states. "The point is an honest answer, not a sales pitch."

Berge, who shares the company's work on Instagram and LinkedIn, has built a patient base that spans high-level executives, entrepreneurs, and current and former professional athletes, including athletes competing at the professional pickleball level. But the emphasis has stayed on accessibility. Thousands of patients report meaningful improvements in pain, mobility, and overall vitality, a track record that has made referrals, rather than advertising, the company's most reliable growth channel.

Nearly a decade in a field where most entrants don't last two years is its own credential. Regenerative Revival's approach, education first, patient-first protocols, science-backed methods, and a vetted practitioner network, has positioned it as one of the more established names in direct-to-patient regenerative care.

More at regenerativerevival.com and on Instagram.